<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110122005663N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-11-09</date_registration>
      <primary_sponsor>Rasht University of Medical Sciences</primary_sponsor>
      <public_title>Comparison the effect of acupressure and massage with ice on Hugo’s point on pain and Physiological parameters related to chemotherapy drug injection in children with acute lymphoblastic leukemia, clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison the effect of acupressure and massage with ice on Hugo’s point on pain and Physiological parameters related to chemotherapy drug injection in children with acute lymphoblastic leukemia, clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59809</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Crossover, Purpose: Supportive, Other design features: The study method has two implementation phases. In the first phase, for group A, ice massage is performed at Hugo point and for group B, acupressure. Then, after a month of cleansing period, in the second phase, for group A, acupressure and for group B, ice massage is performed. The study is a crossover clinical trial, Randomization description: Four random blocks will be used for random assignment of samples to two groups of ice massage at Hugo point (group A) and acupressure (group B). The number of blocks required in this study is 13 blocks, based on which random allocation will be done. The sequence of random assignment of samples to two groups of ice massage at Hugo point (group A) and acupressure (group B) is determined through Random allocation online software. The sequence list of samples A and B will be kept in a sealed envelope in the nursing office of 17 Shahrivar Hospital in Rasht. After starting the study, it will be opened by the main researcher and based on gradual referrals, children in one of groups A or B Will be located and will continue until the estimated sample size in each group is reached, Blinding description: In order to blind the researcher and prevent the effect of mentality on the research results, acupressure and ice massage at Hugo point will be done by one of the members of the research team (main researcher) and the measurement of pain and physiological indicators will be done by the researcher.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Acute lymphoblastic leukemia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the first phase of the operation, in the intervention group, ice massage at the Hugo point is performed 5 minutes before the injection of chemotherapy by the main researcher for the child. To start the massage, first the child is placed on his back in a calm, comfortable and lying position. To determine the Hugo point, place the child's thumb in the abduction position, in which case, a prominent muscular peak (corresponding to the muscle approaching the thumb) located in the middle of the angle between the first and second bones of the palm, between the thumb and the finger. The point is on the back of the hand, the point is Hugo. Then place the hand Hugo point where the injection is not done, for one minute using a piece of ice (2 cm in diameter) wrapped in plastic gloves and a single layer of cotton cloth, using the soft part of the thumb in a rotating manner. , Press in a clockwise direction with an average pressure of 3 to 4 kg, so that the maximum pressure time is cut off one minute at a time and then 10 seconds, and lasts for a total of 5 minutes. Then, after one month and in the second phase of the implementation, acupressure intervention will be performed for this group. Intervention 2: Control group: In the first phase, in the control group, Hugo point acupressure is performed by the principal investigator for the child 5 minutes before the chemotherapy drug is injected. To start work, first the child is placed on his back in a calm, comfortable and lying position. To determine the Hugo point, place the child's thumb in the abduction position, in which case, a prominent muscular peak (corresponding to the muscle approaching the thumb) located in the middle of the angle between the first and second bones of the palm, between the thumb and the finger. The point is on the back of the hand, the point is Hugo. Then press the hand Hugo point where the injection is not done, with the thumb, in a clockwise direction, with a deep pressure of 3 to 4 kg, so that the maximum pressure time per time The pressure is turned off for one minute and then for 10 seconds and lasts for a total of 5 minutes. After a month and in the second phase of the performance, an ice massage intervention will be performed at Hugo Point for this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is After sampling and completion of the project implementation phase, a decision will be made.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahshid Mirzaei Taklimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti School of Nursing and Midwifery, Daneshjoo Street, Beheshti Highway</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4146939841</zip>
        <telephone>+98 13 3355 5056</telephone>
        <email>mahshidmirzaie2015@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahshid Mirzaei Taklimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti School of Nursing and Midwifery, Daneshjoo Street, Beheshti Highway</address>
        <city>Rasht</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4146939841</zip>
        <telephone>+98 13 3355 5056</telephone>
        <email>mahshidmirzaie2015@gmail.com</email>
        <affiliation>Rasht University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children aged 3-12 years
With acute lymphoblastic leukemia
One month has passed since the diagnosis
Treated with Vincristine Chemotherapy
Do not use the catheter port to prescribe chemotherapy
No genetic or mental illness
Organ health at the massage point
Not receiving acupressure and ice massage at Hugo Point before the study
Do not take painkillers 8 hours before chemotherapy injection</inclusion_criteria>
      <agemin>3 years</agemin>
      <agemax>12 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Reluctance to collaborate in the study
Inadequate and severe mental and physical conditions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>C91.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute lymphoblastic leukemia [ALL]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the first phase of the operation, in the intervention group, ice massage at the Hugo point is performed 5 minutes before the injection of chemotherapy by the main researcher for the child. To start the massage, first the child is placed on his back in a calm, comfortable and lying position. To determine the Hugo point, place the child's thumb in the abduction position, in which case, a prominent muscular peak (corresponding to the muscle approaching the thumb) located in the middle of the angle between the first and second bones of the palm, between the thumb and the finger. The point is on the back of the hand, the point is Hugo. Then place the hand Hugo point where the injection is not done, for one minute using a piece of ice (2 cm in diameter) wrapped in plastic gloves and a single layer of cotton cloth, using the soft part of the thumb in a rotating manner. , Press in a clockwise direction with an average pressure of 3 to 4 kg, so that the maximum pressure time is cut off one minute at a time and then 10 seconds, and lasts for a total of 5 minutes. Then, after one month and in the second phase of the implementation, acupressure intervention will be performed for this group.</i_keyword>
      <i_keyword>Control group: In the first phase, in the control group, Hugo point acupressure is performed by the principal investigator for the child 5 minutes before the chemotherapy drug is injected. To start work, first the child is placed on his back in a calm, comfortable and lying position. To determine the Hugo point, place the child's thumb in the abduction position, in which case, a prominent muscular peak (corresponding to the muscle approaching the thumb) located in the middle of the angle between the first and second bones of the palm, between the thumb and the finger. The point is on the back of the hand, the point is Hugo. Then press the hand Hugo point where the injection is not done, with the thumb, in a clockwise direction, with a deep pressure of 3 to 4 kg, so that the maximum pressure time per time The pressure is turned off for one minute and then for 10 seconds and lasts for a total of 5 minutes. After a month and in the second phase of the performance, an ice massage intervention will be performed at Hugo Point for this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Score of pain due to chemotherapy injection. Timepoint: Before the intervention, 5 seconds before the injection and 15 seconds after the injection of chemotherapy. Method of measurement: Oucher's pain intensity self-measurement scale.</prim_outcome>
      <prim_outcome>Percentage of arterial blood oxygen saturation. Timepoint: Before the intervention, 5 seconds before the injection and 15 seconds after the injection of chemotherapy. Method of measurement: Pulse oximeter device.</prim_outcome>
      <prim_outcome>Heart rate(pulse). Timepoint: Before the intervention, 5 seconds before the injection and 15 seconds after the injection of chemotherapy. Method of measurement: Pulse oximeter device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Rasht University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-27</approval_date>
        <contact_name>Ethics committee of Guilan University of Medical Sciences</contact_name>
        <contact_address>Vice Chancellor for Research and Technology of Guilan University of Medical Sciences, in front of 17 Shahrivar hospital, Shahid Siadati Street, Namjoo Street. Rasht Guilan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
